I would expect another RNS soon9 Sep 2021 11:55
Good results from a randomised double blinded trial. It has shown to have no adverse effects.
Also to note: The data from ARCADIA supports continued investigation of AZD1656 for the treatment of patients with COVID-19, with or without diabetes, in future clinical trials.
Due to the nature of this treatment, i will expect this next trial to begin quite quickly due to the backings.